Looking forward to #ASV2023! Come hear how we applied our RNA platform to target a nonenveloped virus #EVD68 (not as straightforward as enveloped viruses). See W16-9 (@DrNikkiWarner21 ) for the vaccine story and W16-1 (me) for the RNA-launched nanobody story. We applied an integrated approach using replicon RNA to develop the vaccine, use that to discover nanobodies, and then launch those from the same platform.
If you are a virologist that would like to know more about NIH fellowships, R01/R21 application processes, what's new in peer review study sections, etc. I'll be set up at a table and available during the Sat. evening social at the #ASV2023 conference in 2 days. Dont hesitate to reach out!. #virology
American Society for Virology joins Mastodon! We want to connect to all of our virology friends! #ASV2023